Prohance and Paleness - a phase IV clinical study of FDA data

Summary:

Paleness is reported as a side effect among people who take Prohance (gadoteridol), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Omniscan, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Paleness when taking Prohance. It is created by eHealthMe based on reports of 3,733 people who have side effects when taking Prohance from the FDA, and is updated regularly.

What is Prohance?

Prohance has active ingredients of gadoteridol. eHealthMe is studying from 3,734 Prohance users. Check the latest studies of Prohance.

What is Paleness?

Paleness (unusual lightness of skin colour) is found to be associated with 1,558 drugs and 2,117 conditions by eHealthMe. Check the latest studies of Paleness.

On Jul, 31, 2026

3,733 people reported to have side effects when taking Prohance.
Among them, 40 people (1.07%) have Paleness.

Among these 40 people:

How long have people been on Prohance when they have Paleness? *

What is the gender of people who have Paleness when taking Prohance? *

female: 45 %
male: 55 %

What is the age of people who have Paleness when taking Prohance? *

What are other drugs people take besides Prohance? *

What are other side effects people have besides Paleness? *

Nausea (feeling of having an urge to vomit): 18 people, 45.00%
Hypotension (abnormally low blood pressure): 9 people, 22.50%
Skin Discoloration: 7 people, 17.50%
Hyperhidrosis (abnormally increased sweating): 7 people, 17.50%
Chest Pain: 7 people, 17.50%
Dizziness: 6 people, 15.00%
Weakness: 6 people, 15.00%
Sweating Increased (excess sweating): 6 people, 15.00%
Skin - Clammy: 6 people, 15.00%
Fatigue (feeling of tiredness): 5 people, 12.50%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 2 people, 5.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.00%
Renal Artery Stenosis (narrowing of renal artery): 1 person, 2.50%
Nuclear Magnetic Resonance Imaging Abdominal: 1 person, 2.50%
High Blood Pressure: 1 person, 2.50%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Prohance and have Paleness?

- Check whether Paleness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prohance:

Prohance (3,734 reports)

Paleness treatments and more:

Paleness (34,670 reports)

Browse all side effects of Prohance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paleness:

Paleness (1,558 drugs)

Browse all the conditions that are associated with Paleness:

Paleness (2,117 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gadoteridol (the active ingredients of Prohance) and Prohance (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.